Exsure
PrivateLast Round
Seed
Jan 22, 2025
Total Funding Raised
$349,000
Company Overview
Exsure is a biotechnology company that develops an exosome-based drug delivery platform for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exsure Comparables
Compare Exsure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exocan Healthcare Technologies | 81% | |
| EviCure | 77% | |
| Evox Therapeutics | 69% |
Exsure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 22, 2025 |
Key People
Founding team and executive leadership
Exsure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IIT Mandi Catalyst | Seed |
| Unicorn India Ventures | Seed |
| Venture Center | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Monthly visitors increased 79% MoM.
- Nov 8, 2025
Monthly visitors increased 80% MoM.
Exsure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exsure's valuation, stock price, and market status.
Is Exsure a public or private company?
Exsure is a private company.
What is the current stock price of Exsure?
Exsure is a private company with no public stock price. No recent secondary market data is available.
How much is Exsure worth (valuation)?
Valuation information for Exsure is not publicly available.
Can I buy Exsure stock?
Exsure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Exsure's last funding round?
Exsure's most recent funding round was Seed on January 22, 2025.
Who are the main investors in Exsure?
Key investors in Exsure include Unicorn India Ventures.
Will Exsure IPO soon?
No public IPO plans have been announced for Exsure.
How can I track Exsure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exsure's secondary market activity and sign up for updates.